Clinical Trial Update: Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity [Phase 1]

View source ↗

Summary

This clinical trial update reports the results of a Phase 1 single and multiple ascending dose study of AMG 133 in adults with obesity. The study has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• AMG 133

Snippet

Sponsor: Amgen | Conditions: Obesity | Phase 1 | Status: COMPLETED | Results posted: 2025-12-10